Pregled po projektu: Uporaba kardiovaskularnih lijekova i značaj farmakoekonomskih procjena (MB: MZOS-062-0620063-0060)
Pronađeno 75 radova
-
1.Kučan, Marta; Mršić-Pelčić, Jasenka; Vitezić, DinkoAntihypertensive Drugs in Croatia: What Changes the Drug Usage Patterns? // Clinical therapeutics, 40 (2018), 7; 1159-1169 doi:10.1016/j.clinthera.2018.05.018 (međunarodna recenzija, članak, znanstveni)
-
2.Inotai, András; Prins, Christiaan; Csanádi, Marcell; Vitezić, Dinko; Codreanu, Catalin; Kaló, ZoltánIs there a reason for concern or is it just hype? – A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars // Expert opinion on biological therapy, 17 (2017), 8; 915-926 doi:10.1080/14712598.2017.1341486 (međunarodna recenzija, članak, znanstveni)
-
3.Vitezić, Dinko; Kučan, MartaChanges In Antihypertensive Drugs Usage in Croatia During the Fourteen-year period // Pharmaca 2016 ; 52 (Supp.1) / Vitezić, Dinko ; Hren, Rok (ur.).
Bled, Slovenija, 2016. str. 63-63 (predavanje, međunarodna recenzija, sažetak, znanstveni) -
4.Vitezić, DinkoPharmacoeconomics and drug value assessment // Abstract Book, 8th Croatian Congress of Pharmacology with International Participation
Split, Hrvatska, 2016. str. 52-52 (pozvano predavanje, međunarodna recenzija, sažetak, znanstveni) -
5.Vitezić, DinkoBiosimilar drugs and the similarity concept // Abstract Book, 8th Croatian Congress of Pharmacology with International Participation
Split, Hrvatska, 2016. str. 25-25 (pozvano predavanje, međunarodna recenzija, sažetak, znanstveni) -
6.Kučan, Marta; Vitezić, DinkoThe Analysis Of Lipid Modifying Agents Usage In Croatia During The Fifteen-Year Period // Abstracts Presented at the European Association for Clinical Pharmacology and Therapeutics Focus Meeting 2016: How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic– 3E Assessment / Richard I. Shader (ur.).
Amsterdam : Boston : Jena : London: Elsevier, 2016. str. e10-e10 (pozvano predavanje, međunarodna recenzija, sažetak, znanstveni) -
7.Vitezić, DinkoPharmacoeconomics: How It Can Be Applied To Support Decisions In Health Care? // Abstracts Presented at the European Association for Clinical Pharmacology and Therapeutics Focus Meeting 2016: How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic– 3E Assessment / Richard I. Shader (ur.).
Amsterdam : Boston : Jena : London: Elsevier, 2016. str. e13-e13 (pozvano predavanje, međunarodna recenzija, sažetak, znanstveni) -
8.Kaló, Zoltan; Vitezić, DinkoImplementation of Pharmacoeconomics to Support Pharmaceutical R&D Decisions: Workshop // Abstracts Presented at the European Association for Clinical Pharmacology and Therapeutics Focus Meeting 2016: How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic– 3E Assessment / Richard I. Shader (ur.).
Amsterdam : Boston : Jena : London: Elsevier, 2016. str. e19-e19 (predavanje, međunarodna recenzija, sažetak, stručni) -
9.Kalo, Zoltan; Csanadi, Marcell; Vitezić, Dinko; Huić, Mirjana; Husereau, Don; Kristensen, Finn, BørlumComparison of current and preferred status of HTA implementation in central and eastern europen countries // Value Health 2015 ; 18(7)
Milano, Italija: Esevier, 2015. str. A538-A538 (poster, međunarodna recenzija, sažetak, znanstveni) -
10.Vitezić, DinkoPharmacoeconomic analysis in Alzheimer’s disease: What is the impact of diagnostic timing? // Neurologia Croatica / Šimić, Goran ; Mimica, Ninoslav (ur.).
Zagreb, 2014. str. 54-54 (pozvano predavanje, međunarodna recenzija, sažetak, znanstveni) -
11.Vitezić, DinkoFactors influencing pharmacoeconomic assessment of new drugs in dieabetes mellitus treatment // Abstract Book, First Macedonian and Fourth Adriatic Congress on Pharmacoeconomics and Outcomes Research / Suturkova, Ljubica ; Vitezić, Dinko (ur.).
Ohrid, Sjeverna Makedonija, 2014. str. 15-16 (predavanje, međunarodna recenzija, sažetak, znanstveni) -
12.Kalo, Zoltan; Vitezić, DinkoHow pharmacoeconomics should be applied to support decisions in lower income European countries? // Abstract Book, First Macedonian and Fourth Adriatic Congress on Pharmacoeconomics and Outcomes Research / Suturkova, Ljubica ; Vitezić, Dinko (ur.).
Ohrid, Sjeverna Makedonija, 2014. str. 11-11 (pozvano predavanje, međunarodna recenzija, sažetak, stručni) -
13.Vitezić, Dinko; Kučan, Marta; Mršić-Pelčić, Jasenka; Vitezić, MiomiraLipid modifying agents usage in Croatia during the 5-year period // Basic Clin Pharmacol Toxicol / Brøsen, Kim (ur.).
Cape Town, Južnoafrička Republika, 2014. str. 74-74 (poster, međunarodna recenzija, sažetak, znanstveni) -
14.Inotai, András; Petrova, Guenka; Vitezić, Dinko; Kaló, ZoltanBenefits of investment into modern medicines in Central-Eastern European countries // Expert Review of Pharmacoeconomics & Outcomes Research, 14 (2014), 1; 71-79 doi:10.1586/14737167.2014.868314 (međunarodna recenzija, članak, znanstveni)
-
15.Knežević, Aleksandar; Vitezić, DinkoSmjernice u propisivanju hipolipemičkih lijekova // Klinička farmakologija / Francetić, Igor ; Vitezić, Dinko (ur.).
Zagreb: Medicinska naklada, 2014. str. 371-378 -
16.Vitezić, Dinko; Knežević, AleksandarSmjernice u propisivanju lijekova u hipertenziji // Klinička farmakologija / Francetić, Igor ; Vitezić, Dinko (ur.).
Zagreb: Medicinska naklada, 2014. str. 359-370 -
17.Vitezić, Dinko; Macolić Šarinić, ViolaFarmakoekonomika // Klinička farmakologija / Francetić, Igor ; Vitezić, Dinko (ur.).
Zagreb: Medicinska naklada, 2014. str. 106-133 -
18.Vitezić, DinkoVažnost smjernica i farmakoekonomike u liječenju arterijske hipertenzije // Medix : specijalizirani medicinski dvomjesečnik, 19 (2013), 104/105; 246-251 (podatak o recenziji nije dostupan, članak, stručni)
-
19.Vitezić, Dinko; Milinović, JasminkaClinical and Noninterventional Trials Assessment in Croatia // Clin Ther 2013 ; 35(8)
Ženeva, Švicarska, 2013. str. e7-e7 (poster, međunarodna recenzija, sažetak, znanstveni) -
20.Vitezić, Neda; Lovrić, Ljiljana; Kučan, MartaComparative analysis of price dynamics of original and generic simvastatine and atorvastatine and the discount factor applicable in the Croatia // Konačni program i sažeci Trećeg hrvatskog i trećeg jadranskog kongresa farmakoekonomike i istraživanja ishoda liječenja / Pharmaca : hrvatski časopis za farmakoterapiju, suppl. 2013
Zagreb: Hrvatsko društvo za kliničku farmakologiju i terapiju, 2013. str. 55-55 (predavanje, podatak o recenziji nije dostupan, sažetak, znanstveni) -
21.Vitezić, Dinko; Mimica, NinoslavIntroduction of anti-dementia drugs in Croatia : epidemiological and budget impact analysis // Abstracts of the 12th Alzheimer's Association International Conference ; u: Alzheimer's & Dementia 8 (2012)(4-S2) (A1-A8, P1-P742)
New York (NY): Elsevier, 2012. str. P563-P563 (poster, međunarodna recenzija, sažetak, znanstveni) -
22.Vitezić, Dinko; Hadžić-Kostrenčić, Carmen; Petković, Marija; Dobrila-Dintinjana, Renata; Vitezica, Pero; Mršić-Pelčić, JasenkaVinorelbine in patients with non-small lung cancer: budget impact analysis // Value health 2012 ; 15 (7)
Berlin, Njemačka, 2012. str. 415-415 (poster, međunarodna recenzija, sažetak, znanstveni) -
23.Vitezić, Dinko; Mađarević, Tomislav; Gantumur, Monja; Buble, Tonći; Vitezić, Miomira; Kovačević, Miljenko; Mršić-Pelčić, Jasenka; Šestan, BrankoDrug usage by outpatients in Croatia during an 8-year period: Influence of changes in pricing policy // International journal of clinical pharmacology and therapeutics, 50 (2012), 7; 483-489 doi:10.5414/CP201686 (međunarodna recenzija, članak, znanstveni)
-
24.Vitezić, Dinko; Lovreček, DijanaEconomic impact of clinical trials on the health care systems // Basic and Clinical Pharmacology and Toxicology 109(Supp. 1) / Brøsen, Kim (ur.).
Budimpešta, Mađarska: Nordic Association for the Publication of BCPT, 2011. str. 10-10 (poster, međunarodna recenzija, sažetak, znanstveni) -
25.Vitezić, Dinko; Kučan, Marta; Vitezić, Miomira; Kovačević, Miljenko; Mršić-Pelčić, JasenkaBeta-blockers and diuretics usage in Croatia and Slovenia during a nine-year period // Value Health 2011 ; 14(3): A49
Baltimore (MD), Sjedinjene Američke Države, 2011. str. 49-49 (poster, međunarodna recenzija, sažetak, ostalo)
